Franklin Resources Portfolio holdings
Franklin Resources, Inc., commonly known as Franklin Templeton, was founded in 1947 by Rupert H. Johnson, Sr., and is headquartered in San Mateo, California, operating as a global investment management firm managing hundreds of billions in assets. The company offers a wide range of investment products, including mutual funds, ETFs, fixed-income portfolios, and alternative investments, serving individual investors, financial advisors, and institutions across over 150 countries. Known for its acquisition-driven growth—such as the 1992 purchase of Templeton Investments and the 2020 addition of Legg Mason—Franklin Templeton combines diverse strategies under a single brand, emphasizing both active management and income-focused solutions like its flagship Franklin Income Fund. With a reputation for adaptability and a client-centric approach, it remains a major player in the global asset management industry.
Top Buys
| 1 |
Bank of America
BAC
|
+$635M |
| 2 |
Marathon Petroleum
MPC
|
+$440M |
| 3 |
T-Mobile US
TMUS
|
+$427M |
| 4 |
Air Products & Chemicals
APD
|
+$344M |
| 5 |
Merck
MRK
|
+$339M |
Top Sells
| 1 |
Alibaba
BABA
|
+$821M |
| 2 |
Bank of America Series L
BAC.PRL
|
+$453M |
| 3 |
Oracle
ORCL
|
+$420M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$377M |
| 5 |
International Paper
IP
|
+$350M |
Sector Composition
| 1 | Technology | 20.67% |
| 2 | Healthcare | 15.46% |
| 3 | Financials | 11.91% |
| 4 | Consumer Discretionary | 8.71% |
| 5 | Industrials | 8.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
VYNE Therapeutics
VYNE
$8.04M
| $10.7M | ﹤0.01% |
93,848
+4
| +0% | +$455 |
|
902
Vanguard Total International Bond ETF
BNDX
$68.6B
| $10.7M | ﹤0.01% |
182,238
-1,532
| -0.8% | -$89.7K |
|
903
VeriSign
VRSN
$26.9B
| $10.7M | ﹤0.01% |
49,211
+41,427
| +532% | +$8.97M |
|
904
Vaxcyte
PCVX
$4.23B
| $10.6M | ﹤0.01% |
400,076
+6
| +0% | +$159 |
|
905
Kezar Life Sciences
KZR
$29.6M
| $10.6M | ﹤0.01% |
202,695
+5
| +0% | +$261 |
|
906
Westlake Corp
WLK
$11.3B
| $10.5M | ﹤0.01% |
129,087
-49,358
| -28% | -$4.03M |
|
907
XP
XP
$9.98B
| $10.3M | ﹤0.01% |
260,491
+33,504
| +15% | +$1.33M |
|
|
MTCR
908
DELISTED
Metacrine, Inc. Common Stock
MTCR
| $10.3M | ﹤0.01% |
1,309,057
+693,673
| +113% | +$5.45M |
|
|
PANA.U
909
DELISTED
Panacea Acquisition Corp. Units, each consisting of one share of Class A common stock and one-third
PANA.U
| $10.2M | ﹤0.01% |
800,000
| – | – |
|
910
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.4B
| $10.1M | ﹤0.01% |
183,857
+5,028
| +3% | +$277K |
|
911
Tetra Tech
TTEK
$9.45B
| $10.1M | ﹤0.01% |
437,240
-1,495
| -0.3% | -$34.6K |
|
912
RenaissanceRe
RNR
$11.3B
| $10M | ﹤0.01% |
60,550
+5,957
| +11% | +$988K |
|
913
Regency Centers
REG
$13.1B
| $9.9M | ﹤0.01% |
217,180
-26,463
| -11% | -$1.21M |
|
|
HES
914
DELISTED
Hess
HES
| $9.89M | ﹤0.01% |
187,334
+1,202
| +0.6% | +$63.5K |
|
915
Revvity
RVTY
$9.86B
| $9.86M | ﹤0.01% |
68,705
+55,973
| +440% | +$8.03M |
|
916
Americold
COLD
$3.85B
| $9.73M | ﹤0.01% |
260,696
-24,488
| -9% | -$914K |
|
917
Carrier Global
CARR
$53.5B
| $9.71M | ﹤0.01% |
257,425
+28,693
| +13% | +$1.08M |
|
918
Rollins
ROL
$28B
| $9.67M | ﹤0.01% |
247,500
-8,591
| -3% | -$336K |
|
919
Black Diamond Therapeutics
BDTX
$190M
| $9.62M | ﹤0.01% |
300,107
+7
| +0% | +$224 |
|
920
Arq
ARQ
$302M
| $9.51M | ﹤0.01% |
1,729,812
+1,560
| +0.1% | +$8.58K |
|
921
Ryanair
RYAAY
$31.6B
| $9.47M | ﹤0.01% |
215,450
-20,250
| -9% | -$890K |
|
922
MKS Inc. Common Stock
MKSI
$7.74B
| $9.44M | ﹤0.01% |
62,755
-90,607
| -59% | -$13.6M |
|
923
Generac Holdings
GNRC
$11.2B
| $9.44M | ﹤0.01% |
41,507
+5,607
| +16% | +$1.28M |
|
|
MGP
924
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $9.43M | ﹤0.01% |
301,113
-13,248
| -4% | -$415K |
|
925
iShares S&P 500 Growth ETF
IVW
$65.3B
| $9.41M | ﹤0.01% |
147,420
-4,760
| -3% | -$304K |
|